Published in Cancer Immunol Immunother on June 14, 2012
B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer. Int J Clin Exp Pathol (2014) 1.10
VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer Immunol Res (2014) 0.94
B7-H6 expression in non-small cell lung cancers. Int J Clin Exp Pathol (2014) 0.87
T cell coinhibition and immunotherapy in human breast cancer. Discov Med (2012) 0.85
Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors. Oncotarget (2016) 0.83
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. Oncoimmunology (2015) 0.83
B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer. Int J Clin Exp Pathol (2015) 0.81
Evolving Concepts: Immunity in Oncology from Targets to Treatments. J Oncol (2015) 0.81
B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer. Am J Transl Res (2015) 0.81
Parapharyngeal liposarcoma: a case report. Diagn Pathol (2013) 0.81
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma. J Transl Med (2016) 0.79
Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation. J Transl Med (2014) 0.78
Immune checkpoint blockade therapy for bladder cancer treatment. Investig Clin Urol (2016) 0.78
Clinical significance of B7-H6 protein expression in astrocytoma. Onco Targets Ther (2016) 0.77
Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. Biomed Res Int (2015) 0.77
Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Oncotarget (2016) 0.77
B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. Int J Clin Exp Pathol (2015) 0.77
Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget (2017) 0.77
Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer. Oncoimmunology (2016) 0.76
Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis. Oncotarget (2017) 0.75
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy. Oncotarget (2016) 0.75
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. Oncoimmunology (2015) 0.75
Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer. Oncol Lett (2017) 0.75
Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer. Oncol Lett (2017) 0.75
LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol (2011) 1.95
CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum (2009) 1.73
Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis Rheum (2011) 1.48
Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun (2012) 1.48
High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). J Immunol (2007) 1.02
Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation. J Transl Med (2014) 0.78
Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts (2017) 0.75